Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 31 citing articles:

Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages
Harold Marcotte, Yunlong Cao, Fanglei Zuo, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 3
Open Access | Times Cited: 18
Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target
Lixiao Xing, Zhimin Liu, Xinling Wang, et al.
Cell (2025)
Closed Access | Times Cited: 1
Neutralization of SARS-CoV-2 BA.2.86 and JN.1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD
Zezhong Liu, Jie Zhou, Weijie Wang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101445-101445
Open Access | Times Cited: 10
A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern
Lixiao Xing, Xinfeng Xu, Wei Xu, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 597-597
Open Access | Times Cited: 32
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
William R. Strohl, Zhiqiang Ku, Zhiqiang An, et al.
BioDrugs (2022) Vol. 36, Iss. 3, pp. 231-323
Open Access | Times Cited: 32
Broadly neutralizing antibodies against COVID-19
Daming Zhou, Jingshan Ren, Elizabeth E. Fry, et al.
Current Opinion in Virology (2023) Vol. 61, pp. 101332-101332
Open Access | Times Cited: 19
Preparation and characterization of a monoclonal antibody against MCP of largemouth bass ranavirus and investigation of the virus's tissue tropism
Yuhui Wang, Yaoda Wang, Tianmei Hu, et al.
Aquaculture (2025), pp. 742170-742170
Closed Access
Effect of Different Adjuvants on Immune Responses Elicited by Protein-Based Subunit Vaccines against SARS-CoV-2 and Its Delta Variant
Naru Zhang, Qianting Ji, Zezhong Liu, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 501-501
Open Access | Times Cited: 25
Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer
Wuqiang Zhan, Xiaolong Tian, Xiang Zhang, et al.
Journal of Virology (2022) Vol. 96, Iss. 16
Open Access | Times Cited: 25
Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2
Meng Yuan, Yiquan Wang, Huibin Lv, et al.
Cell Reports (2022) Vol. 41, Iss. 7, pp. 111650-111650
Open Access | Times Cited: 24
Development of variant‐proof severe acute respiratory syndrome coronavirus 2, pan‐sarbecovirus, and pan‐β‐coronavirus vaccines
Jie Zhou, Zezhong Liu, Guangxu Zhang, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 21
A human antibody derived from original SARS-CoV-2 infection effectively neutralizes omicron
Tingting Li, Bingjie Zhou, Haoyu Dong, et al.
Advanced Biotechnology (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 3
A novel cyclic γ-AApeptide-based long-acting pan-coronavirus fusion inhibitor with potential oral bioavailability by targeting two sites in spike protein
Songyi Xue, Xinling Wang, Lei Wang, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 17
Fortuitous Somatic Mutations during Antibody Evolution Endow Broad Neutralization against SARS-CoV-2 Omicron Variants
Jianbo Wu, Zhenguo Chen, Yidan Gao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 17
Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor
Wan Ni Chia, Chee Wah Tan, Aaron Tan, et al.
Science Advances (2023) Vol. 9, Iss. 30
Open Access | Times Cited: 8
Emergence of SARS and COVID-19 and preparedness for the next emerging disease X
Ben Hu, Hua Guo, Hao-Rui Si, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 1, pp. 1-18
Closed Access | Times Cited: 2
Using PyMOL to Understand Why COVID-19 Vaccines Save Lives
Celia Maya
Journal of Chemical Education (2023) Vol. 100, Iss. 3, pp. 1351-1356
Open Access | Times Cited: 5
1,7-Bis(4-hydroxyphenyl)-1,4,6-heptatrien-3-one inhibits SARS-CoV-2 by targeting the nucleocapsid protein
Yang Liu, Kuiru Sa, Wei Xu, et al.
Acta Materia Medica (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 5
Broad strategies for neutralizing SARS-CoV-2 and other human coronaviruses with monoclonal antibodies
Zhiyang Ling, Chunyan Yi, Xiaoyu Sun, et al.
Science China Life Sciences (2022) Vol. 66, Iss. 4, pp. 658-678
Open Access | Times Cited: 9
A subunit‐based influenza/SARS‐CoV‐2 Omicron combined vaccine induced potent protective immunity in BALB/c mice
Naru Zhang, Zihui Ye, Cun Li, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Open Access | Times Cited: 1
STING agonists as promising vaccine adjuvants to boost immunogenicity against SARS-related coronavirus derived infection: possible role of autophagy
Aysa Rezabakhsh, M. Reza Sadaie, Alireza Ala, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Zoonotic Origin and Evolution of SARS Coronavirus
Zheng‐Li Shi, Ben Hu, Lin‐Fa Wang
Elsevier eBooks (2024), pp. 841-861
Closed Access | Times Cited: 1
Fortuitous somatic mutations during antibody evolution endow broad neutralization against SARS-CoV-2 Omicron variants
Jianbo Wu, Zhenguo Chen, Yidan Gao, et al.
Cell Reports (2023) Vol. 42, Iss. 5, pp. 112503-112503
Open Access | Times Cited: 4
Acriflavine and proflavine hemisulfate as potential antivirals by targeting Mpro
Jing Liang, Mengzhu Zheng, Wei Xu, et al.
Bioorganic Chemistry (2022) Vol. 129, pp. 106185-106185
Open Access | Times Cited: 7
Identification of B-Cell Epitopes on Capsid Protein Reveals Two Potential Neutralization Mechanisms in Red-Spotted Grouper Nervous Necrosis Virus
Zhiqi Zhang, Jing Xing, Xiaoqian Tang, et al.
Journal of Virology (2023) Vol. 97, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top